Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial
Authors
Mukherjee, S.Hurt, C.
Cox, C.
Radhakrishna, Ganesh
Gwynne, S.
Bateman, A. R.
Gollins, S.
Hawkins, M. A.
Canham, J.
Grabsch, H. I.
Falk, S.
Sharma, R. A.
Ray, R.
Roy, R.
Wade, W.
Maggs, R.
Sebag-Montefiore, D. J.
Maughan, T.
Griffiths, G. O.
Crosby, T. D. L.
Affiliation
University of Oxford, OxfordIssue Date
2020